Challenge

A well-capitalized European pharma company needed on-the-ground support with a search for late stage therapeutics, devices and diagnostics acquisition opportunities in the US. Alacrita was engaged to help identify such opportunities and to broker interactions with suitable companies.

Solution

We conducted extensive desk research and used our wide industry network to identify a long list of opportunities that fit our client’s criteria. Working with the client, we prioritized those opportunities that were most closely aligned to their strategic needs. At the request of our client, we contacted each target company to gauge their level of interest in a transaction and then hosted a series of meetings for our client with interested parties in the US. As a result of this work, our client embarked on extensive due diligence on a target company that we identified.